Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2022-02-08 Regulatory Filings
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
Oxilio NXP-001 formulation development contract
Regulatory Filings Classification · 1% confidence The document is identified by the RNS Number and the date (08 February 2022). The content announces a significant service contract signed by Oxilio (a licensee of Nuformix) with Quotient Sciences regarding formulation development for NXP-001. This is a corporate update regarding business progress and licensing activity, not a formal financial report (like 10-K or IR) or a specific regulatory filing like insider trading (DIRS) or dividend announcement (DIV). The document explicitly states it is distributed via 'Reach', which is described as a 'non-regulatory press release distribution service of RNS'. Since it is a general business update distributed via a press release mechanism that is explicitly non-regulatory, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous announcement, or potentially a general corporate update. Given the options, RNS serves as the best general category for non-standard, non-financial regulatory/press announcements distributed through the LSE's system, especially when the content is a business development update.
2022-02-08 English
Adviser Appointments
Regulatory Filings Classification · 1% confidence The document is a short announcement released via RNS (Regulatory News Service) with the RNS Number 2273A. The content announces the appointment of a Financial Adviser/Broker and an Investor Relations adviser. This type of corporate action announcement, which is not a full financial report (like 10-K or IR) or a specific transaction report (like DIRS or POS), fits best under the general category for regulatory announcements that do not fit elsewhere, or potentially a Capital/Financing Update (CAP) if the adviser appointment is directly tied to fundraising. However, since it is explicitly distributed via RNS and is a general corporate update about advisory services, the most appropriate classification based on the provided definitions is the general Regulatory Filings category (RNS), as it is a standard regulatory news release.
2022-02-01 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an official announcement filed via RNS (RNS Number: 1883A) dated January 31, 2022. The content explicitly details 'Director/PDMR Shareholding' transactions, specifically the granting of warrants to three individuals identified as Persons Discharging Managerial Responsibilities (PDMRs). This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing.
2022-01-31 English
Result of General Meeting
AGM Information Classification · 1% confidence The document is an official announcement released via RNS (RNS Number: 1561A) on January 31, 2022. The core content explicitly states the 'Result of General Meeting' and provides a detailed table showing the voting results ('For' vs. 'Against') for two specific resolutions passed by poll. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a regulatory filing (RNS), DVA is the more specific and accurate classification for the content provided.
2022-01-31 English
Posting of Circular and Notice of General Meeting
Regulatory Filings Classification · 1% confidence The document is titled 'Posting of Circular and Notice of General Meeting' and explicitly states that a 'circular to shareholders and a notice of general meeting has been sent to shareholders'. It details the purpose of the General Meeting, which is to seek shareholder approval for the second tranche of a conditional subscription (fundraising activity). The content is a letter from the Chairman extracted from the Circular, explaining the financing terms and requesting a vote. This structure—a formal announcement accompanying a document requiring a shareholder vote and detailing meeting logistics—strongly indicates materials related to soliciting votes for a meeting, which aligns with the Proxy Solicitation & Information Statement (PSI) definition, or potentially an AGM-R if the meeting is the AGM. Since it specifically mentions a 'Notice of General Meeting' and seeks approval for resolutions related to financing, it is primarily a proxy/information statement for a general meeting. Given the context of seeking approval for resolutions, PSI is the most precise fit, although AGM-R is also plausible if this meeting is the AGM. However, the core function described is providing the necessary information (the Circular) to support the vote requested in the Notice, making PSI (Proxy Solicitation & Information Statement) the best fit over the general AGM-R category.
2022-01-17 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is clearly identified as an 'RNS Number : 9789X' from 'Nuformix PLC' dated '10 January 2022'. The content explicitly details a 'Director/PDMR Shareholding' transaction, specifically the purchase of shares by Dr Alastair Riddell, an Executive Chairman. This falls under the category of reporting personal share transactions by company directors and executives (insider trades). This matches the definition for Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2022-01-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.